Hopefully, this episode kind of like shed some light on it here, and then I think the talking points that you can tell people again is like, this is a banned substance
We build lasting relationships for better outcomes, not one-off visits
We have made a number of changes to existing protocols, most notably, the use of defined salt concentrations (0.175 M NaCl) in the working buffer, the use of an ApoC-II peptide as a potent, readily available and cost-effective LPL activator, and the use of the nAngptl4 peptide as an LPL-specific inhibitor
We prepare the clinical documentation, submit the request to your Part D plan, and manage any follow-up or appeals
It does not provide medical advice, diagnosis, or treatment recommendations